PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 762 of 779

Advanced search

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Health Canada adopts new approach for in vitro dissolution data for additional strength biowaivers: Notice

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Interim policy for the modernization of the clinical trial framework: Notice

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Health Canada publishes guidance on clinical trials with decentralized elements: Notice

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Drug products

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Health Canada has changed how it screens drug establishment licence applications

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Clinical trials for drugs and health products

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Drugs and health products

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

Proposed interim approach to speed up the review of certain pediatric drugs: Notice

Health CanadaOriginal source

🇨🇦Jan 1, 1970Regulatorycanada.caTier 1 · Regulatory source

What we heard: Consulting on modernizing clinical trials

Health CanadaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

November 2025 Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

February 2026 Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

July 2025 Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Wins CRO Leadership Award for Overall Capabilities - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Clinipace Name Change: Introducing Caidya, a New Name for a Leading Global CRO - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025 - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Welcomes Jay Roberts to its Board of Directors - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

August 2026 Caidya Congratulates Partner MediLink on NMPA Acceptance of the New Drug Application for Tam-Peli (YL201)

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Achieves Medidata Rave TSDV Accreditation, Enhancing Clinical Trial Efficiency and Data Integrity - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970CDMOcaidya.comTier 2 · Direct publisher

Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO - Caidya®

CaidyaOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio to Participate in Upcoming Investor Conferences

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Industrycabalettabio.comTier 1 · Company source

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Cabaletta BioOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 08.15.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 09.24.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 07.31.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 11.19.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 06.24.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 07.21.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 12.17.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 11.24.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 09.22.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 09.03.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

How inflammation may prime the gut for cancer

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 11.20.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 08.22.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 08.07.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 08.08.2025

Broad InstituteOriginal source

🇺🇸Jan 1, 1970Researchbroadinstitute.orgTier 2 · Direct publisher

News 05.19.2025

Broad InstituteOriginal source

🇺🇰Jan 1, 1970Researchbristol.ac.ukTier 2 · Direct publisher

All news feeds | News and features | University of Bristol

University of BristolOriginal source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Voice of the Physician - Christian Dyzmann

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Voice of the Physician - Dr. Jacek Staszewski

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Stroke Visionaries - Katie Chappelle

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Stroke Visionaries: Dr. Wendy Dusenbury

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Stroke Visionaries: Dr. Thanh Nguyen

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source

🇺🇰Jan 1, 1970Devicesbrainomix.comTier 1 · Company source

Stroke Visionaries - Dr. Songül Şenadım

Brainomix (Brainomix 360 e-Stroke for ICH/Stroke)Original source